Tharimmune

Biotechnology company(THAR)

Progetti simili

*Se non è cliccabile, significa che non sono disponibili informazioni dettagliate.

The Ether Machine

Ethereum Yield and Infrastructure Company(Nasdaq:ETHM)

Bitcoin Financial Services Company(NASDAQ: FLD)

Quantum Solutions

AI technology listed company(TSE: 2338.T)

Design and development company（Nasdaq：SRM）

DV8 Public Company Limited

Advertising Media(SET:DV8)

Health technology and investment consulting（NGM：H100）

Cryptocurrency Technology Corporation（Nasdaq：BTCT）

Decentralized Video Streaming (Nasdaq: RUM)

Circa Tharimmune

Notizie

Tag

Digital Asset Treasury

Publicly listed company

Tharimmune, Inc. (THAR) is a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for inflammation and immunology.

Investitori

Liberty City Ventures

DRW Venture Capital

Kraken

Polychain

A

ARK Invest

Dettagli sul fundrasing

Round di finanziamento	Amount	Valutazione	Ora	Investitori
Post-IPO	$540.00M	--	2025-11-03	Liberty City Ventures* DRW Venture Capital* + 3